The Australian market has followed US equities sharply lower over the last week, after US President Trump unveiled a ‘worse than feared’ set of tariffs against major trading partners.
Trump’s broad set of ‘reciprocal’ tariffs includes an additional 34% on China (on top of the 20% previously announced), as well as 20% on the EU and 24% on Japan. Australia and the UK have emerged relatively unscathed, with the base rate of 10% imposed on both countries.
China has responded with a 34% levy on all US imports, while the EU will vote on its proposed US$28 billion of retaliatory tariffs later this week.
While the situation remains fluid, the initial retaliation push is incrementally negative for the global economy, and hence both global and domestic equities.
Recessionary tail risks in the US and globally have risen markedly since the tariff announcements. However, on the bright side, the ASX is relatively well placed (compared to offshore markets) due to a fairly limited direct tariff impost on the Australian economy, the prospect of further RBA rate cuts this year, and a relatively attractive cyclical backdrop (with a return to positive earnings growth in FY26).
High-growth companies and offshore earners have led the pullback
The ASX 200 has fallen 14% from its mid-February highs. The market dislocation has been broad-based, although weakness has been disproportionate within high-growth (e.g. IT) and cyclical sectors (e.g. Energy, Consumer Discretionary, Financials). Meanwhile, defensive sectors (e.g. Utilities, Consumer Staples) have unsurprisingly outperformed in the ‘risk-off’ environment.
Companies with material offshore (particularly US) earnings have been hit particularly hard in the pullback (especially those with cyclical demand profiles), as have companies with leverage to financial markets (e.g. Asset Managers/Investment Banks /Investment Platforms).
In this report, we have taken the opportunity to increase the portfolio’s exposure to high-quality defensives, by adding Woolworths Group and upweighting Brambles. We have also increased our exposure to the gold mining sector by increasing our weighting in Evolution Mining, consistent with our positive outlook for the commodity as a 'safe haven' asset in an uncertain environment. These changes have been funded by the removal of Breville and WEB Travel amidst mounting global macro concerns.
Company Name | Ticker | Drawdown from market peak (14 Feb 2025) | 12 month forward PE | Premium/discount vs 5yr avg | EPS CAGR (FY26/7) | NTM EPS revisions - last 30 days | Focus Portfolio holdings |
Paladin Energy | PDN | -50% | 13.7 | nm | - | -36% | |
Mineral Resources | MIN | -48% | 15.6 | 0% | - | -18% | |
Block | XYZ | -42% | 10.2 | nm | 35% | 0% | |
Viva Energy Group | VEA | -42% | 9.1 | -41% | 41% | 0% | |
Pilbara Minerals | PLS | -41% | 24.5 | nm | - | -2% | |
WiseTech Global | WTC | -38% | 49.9 | -37% | 34% | 0% | x |
Pro Medicus | PME | -38% | 121.4 | 11% | 37% | -4% | |
Reece | REH | -34% | 25.1 | -26% | 13% | -1% | |
James Hardie | JHX | -33% | 12.9 | -37% | 12% | -5% | x |
NEXTDC | NXT | -33% | - | - | 39% | 0% | |
Life360 | 360 | -32% | 34.3 | nm | 53% | 0% | |
IGO | IGO | -32% | 29.7 | 60% | - | 2% | |
Hub24 | HUB | -31% | 41.2 | -9% | 23% | -1% | x |
IDP Education | IEL | -30% | 19.2 | -59% | 24% | 0% | |
South32 | S32 | -29% | 6.9 | -36% | 21% | -5% | x |
Flight Centre | FLT | -28% | 9.7 | -82% | 14% | 0% | |
Bendigo and Adelaide Bank | BEN | -27% | 11.7 | -3% | 0% | 0% | |
Macquarie Group | MQG | -27% | 15.0 | -14% | 12% | -6% | x |
Fortescue | FMG | -27% | 8.4 | -11% | -13% | 0% | |
Goodman Group | GMG | -26% | 20.4 | -17% | 11% | 0% | x |
Reliance Worldwide | RWC | -26% | 11.0 | -33% | 13% | 0% | |
Aristocrat Leisure | ALL | -25% | 20.1 | -8% | 11% | 0% | x |
Ampol | ALD | -25% | 10.8 | -24% | 17% | -1% | |
TechnologyOne | TNE | -24% | 52.0 | 19% | 19% | -1% | x |
Xero | XRO | -23% | 64.2 | -69% | 46% | -2% | x |
Data is accurarate as of 7/4/2025 market close. Source: Refinitiv, Wilsons Advisory.
The Focus Portfolio is relatively well placed to navigate Trump’s announced tariffs on US imports.
Breville (removed from portfolio) has the greatest exposure to the tariffs in a direct sense, given its manufacturing is concentrated outside of the US, while the majority of its product sales are in the US market, which will impact its input costs from FY26. More significantly though, we are incrementally cautious towards Breville due to its exposure to a weakening US consumer outlook.
Elsewhere in the portfolio, we assess only modest impacts for ResMed, Aristocrat and James Hardie, and negligible impacts for CSL and Telix Pharmaceuticals.
Ticker | Company name | Impact | Tariff cost impost |
CSL | CSL | Negligble | CSL's plasma collection network and manufacturing facilities are predominantly located across the US. While a small proportion of CSL's plasma is processed in Switzerland, pharmaceuticals are currently exempt from US tariffs. |
TLX | Telix Pharmaceuticals | Negligble | Telix has confirmed that it does not expect any material impact on its business or supply chain from the announced US tariffs given its extensive US based manufacturing network. Moreover, the business has highlighted that pharmaceuticals are currently exempt from US tariffs. |
RMD | ResMed | Modest | ResMed is largely insulated from US tariffs given its manufacturing facilities are concentrated within the US, as well as in Singapore and Australia where US tariffs at this stage are relatively limited, at 10%. Overall, there is the potential for low to mid single digit impacts to FY26 EPS from tariffs, which doesnt meaningfully alter ResMed's attractive earnings growth outlook. |
ALL | Aristocrat Leisure | Modest | Aristocrat has diversified its supply chain since the pandemic, while its EGM assembly facilities are concentrated in the US (Las Vegas, Oklahoma), although it also has centres in Canada and China. Everything considered, we expect only modest impacts to the manufacturing costs of the land-based business (which we are confident the business can 'pass on' to customers), while Aristocrat's digital businesses will be unaffected by tariffs. |
JHX | James Hardie | Modest | James Hardie's fibre cement is primarily manufactured within the US, however, there are likely to be small impacts to raw materials costs from tariffs of 25% on Canadian pulp (pulp accounts for an estimated ~10-15% of raw materials costs). The company's exposure to tariffs on Canadian pulp is partially insulated by its supplier relationships in the US, New Zealand, and Chile. Guidance is for high-single digit cost inflation in FY26. |
BRG | Breville | High | Currently, 90% of Breville's products are manufactured in China, with the rest coming from the EU, Mexico and Taiwan. It is progressing on plans to diversify manufacturing, looking at Mexico, Indonesia and Cambodia, however, these markets are also set to be heavily tariffed. |
Source: Refinitiv, Wilsons Advisory.
In this highly uncertain market environment, with mounting risks to US/European consumer spending while the Australian economy is relatively insulated from the global trade war, there is value in adding exposure to domestic defensives and gold miners and reducing exposure to US/Europe exposed cyclicals. Accordingly, we have made the following changes to the Focus Portfolio:
Reducing exposure to global cyclical risks
Adding exposure to domestic defensives and gold
Removing Breville: weaker US consumer outlook creates risks to top-line growth
Breville (BRG) has been removed from the Focus Portfolio. We were previously attracted to Breville’s positive top-line momentum in the Americas and EMEA and had expected it to benefit from an improving consumer environment globally. However, the materially increased probability of a US/ global recession has created downside risks to earnings over the medium-term.
The ultimate scale of Trump’s tariffs (and their impact on BRG) has been greater than expected, with significant tariffs not only impacting BRG’s manufacturing in China (as anticipated), but also meaningfully impacting other markets where BRG has existing or planned facilities, including the EU, Taiwan, Indonesia, and Cambodia.
Beyond the direct cost impost of tariffs, even more significant in our view is the likely knock-on effects of the trade war on discretionary consumer spending globally, particularly within the Americas, which accounts for ~55% of BRG’s product sales (EMEA ~25%). The deteriorating consumer outlook presents an incremental headwind to BRG’s top-line growth.
Notwithstanding BRG’s share price pullback, the balance of risks remains skewed to the downside. Valuation wise, BRG currently trades at a 12-month forward PE of ~27x, reflecting a 55% premium to the ASX 200, which is demanding given its significant exposure to the US economy where recession risks are now meaningful.
Removing WEB Travel: uncertain macro picture threatens global travel outlook
WEB Travel (WEB) has been removed from the Focus Portfolio. We have become increasingly cautious around the outlook for global tourism due to the weakening macro picture. This threatens to crimp spending on non-essential items, including travel in WEB’s key regions of EMEA (~50% of TTV) and the Americas (~25% of TTV).
The latest Tourism Economics’ Q1 2025 Travel Industry Monitor (released 29 March 2025) highlighted significantly weaker economic sentiment from ~2/3 of tourism experts, which appears likely to worsen over the near-term after Trump’s tariff announcements.
As such, the clouded outlook for global consumer spending creates downside risks to WEB’s TTV (total transaction volumes) over the medium-term.
In addition, after successive revenue/TTV margin guidance downgrades, we cannot rule out further downside if global travel activity slows (potentially driving increased discounting and greater competitive intensity in the wholesale travel market).
Defensives have unsurprisingly outperformed in this market correction, which has highlighted the key role they play in providing downside protection during periods of market volatility.
With downside risks to the global economy mounting and macro uncertainty remaining elevated, we continue to see value in increasing the portfolio’s exposure to defensives. In Figure 8, we conduct a fundamental screen of defensives on the ASX 200.
Woolworths Group (WOW) has been introduced into the Focus Portfolio at a weight of 4%.
As Australia’s largest (and New Zealand’s second largest) supermarket chain, as well as the owner of Big W and PetStock, WOW benefits from an attractive industry structure (an oligopoly with Coles, Aldi, IGA) and relatively defensive household demand through the economic cycle, given its inherent tilt towards fresh food and other everyday essentials.
There are several key factors that underpin our conviction in WOW at this juncture:
Our primary focus in the current market environment is on quality. Critically, we are confident in the balance sheet strength of each of the Focus Portfolio’s 26 holdings, most of which have only a modest level of gearing, if any.
Moreover, the portfolio is focused on high quality businesses supported by durable competitive advantages, secular growth tailwinds, pricing power, and attractive returns on invested capital. These quality attributes are crucial in what is a deteriorating (and highly uncertain) global macro outlook.
Importantly, we have reduced the portfolio's exposure to global recession tail risks with the removal of Breville and WEB Travel, while our increased weighting in defensives and the gold sector has positioned the portfolio for continued volatility from the rapidly evolving macro environment.
Portfolio characteristics | Focus Portfolio | ASX 300 | +/- | |
Before changes | After changes | |||
Beta | 1.1 | 1.0 | 1.0 | nm |
Fwd Dividend Yield | 3.2% | 3.2% | 3.7% | -0.5% |
Forward P/E | 15.3 | 15.5 | 17.3 | -1.8 |
EPS growth (FY25) | 5.2% | 6.1% | -0.8% | 6.9% |
EPS CAGR (FY26-27) | 12.1% | 11.7% | 7.7% | 4.0% |
Return on Equity (ROE) | 18.2% | 19.0% | 12.2% | 6.8% |
Source: Refinitiv, Wilsons Advisory.
Company Name | Ticker | Portfolio weight | ROIC (ROE*) | Net Debt (Net Cash) / EBITDA |
ANZ | ANZ | 8.0% | 10%* | nm |
CSL | CSL | 8.0% | 14% | 1.6 |
BHP | BHP | 8.0% | 19% | 0.5 |
Westpac | WBC | 5.5% | 10%* | nm |
Santos | STO | 5.0% | 8% | 1.5 |
James Hardie | JHX | 4.0% | 20% | 0.5 |
Woolworths Group* | WOW | 4.0% | 22% | 2.6 |
Evolution Mining | EVN | 4.0% | 17% | 0.4 |
Aristocrat Leisure | ALL | 4.0% | 56% | 0.0 |
Goodman Group | GMG | 4.0% | 11% | -0.3 |
Macquarie Group | MQG | 4.0% | 13%* | nm |
Resmed | RMD | 3.5% | 27% | -0.3 |
Healthco REIT | HCW | 3.0% | 5% | nm |
Collins Foods | CKF | 3.0% | 20% | 0.6 |
Xero | XRO | 3.0% | 32% | -1.7 |
Worley | WOR | 3.0% | 16% | 1.3 |
Telix Pharmaceuticals | TLX | 3.0% | 25% | 0.5 |
Lottery Corporation | TLC | 3.0% | 20% | 2.6 |
CAR Group | CAR | 3.0% | 24% | 1.4 |
South32 | S32 | 3.0% | 11% | -0.1 |
WiseTech | WTC | 3.0% | 28% | -0.4 |
Brambles | BXB | 3.0% | 19% | 1.1 |
MAC Copper | MAC | 2.0% | 6% | 0.5 |
Sandfire Resources | SFR | 2.0% | 9% | 0.1 |
Hub24 | HUB | 2.0% | 36% | nm |
TechnologyOne | TNE | 2.0% | 62% | -1.0 |
Metrics are based on 12 month forward consensus estimates. *New portfolio addition.
Source: Refinitiv, Visible Alpha, Wilsons Advisory.
Greg is an Equity Strategist in the Investment Strategy team at Wilsons Advisory. He is the lead portfolio manager of the Wilsons Advisory Australian Equity Focus Portfolio and is responsible for the ongoing management of the Global Equity Opportunities List.
About Wilsons Advisory: Wilsons Advisory is a financial advisory firm focused on delivering strategic and investment advice for people with ambition – whether they be a private investor, corporate, fund manager or global institution. Its client-first, whole of firm approach allows Wilsons Advisory to partner with clients for the long-term and provide the wide range of financial and advisory services they may require throughout their financial future. Wilsons Advisory is staff-owned and has offices across Australia.
Disclaimer: This communication has been prepared by Wilsons Advisory and Stockbroking Limited (ACN 010 529 665; AFSL 238375) and/or Wilsons Corporate Finance Limited (ACN 057 547 323; AFSL 238383) (collectively “Wilsons Advisory”). It is being supplied to you solely for your information and no action should be taken on the basis of or in reliance on this communication. To the extent that any information prepared by Wilsons Advisory contains a financial product advice, it is general advice only and has been prepared by Wilsons Advisory without reference to your objectives, financial situation or needs. You should consider the appropriateness of the advice in light of your own objectives, financial situation and needs before following or relying on the advice. You should also obtain a copy of, and consider, any relevant disclosure document before making any decision to acquire or dispose of a financial product. Wilsons Advisory's Financial Services Guide is available at wilsonsadvisory.com.au/disclosures.
All investments carry risk. Different investment strategies can carry different levels of risk, depending on the assets that make up that strategy. The value of investments and the level of returns will vary. Future returns may differ from past returns and past performance is not a reliable guide to future performance. On that basis, any advice should not be relied on to make any investment decisions without first consulting with your financial adviser. If you do not currently have an adviser, please contact us and we would be happy to connect you with a Wilsons Advisory representative.
To the extent that any specific documents or products are referred to, please also ensure that you obtain the relevant disclosure documents such as Product Disclosure Statement(s), Prospectus(es) and Investment Program(s) before considering any related investments.
Wilsons Advisory and their associates may have received and may continue to receive fees from any company or companies referred to in this communication (the “Companies”) in relation to corporate advisory, underwriting or other professional investment services. Please see relevant Wilsons Advisory disclosures at www.wilsonsadvisory.com.au/disclosures.